Biotech CEO Urges Congress To Restore SBIR Eligibility To VC-Backed Firms
This article was originally published in The Pink Sheet Daily
Executive Summary
Legislation pending in the House and Senate would restore eligibility to companies majority-funded by venture capital.
You may also be interested in...
Revamp Of Small Business Funding Scheme Set For Yet Another Delay By Congress
SBIR update: House and Senate can't agree in time on bill prized by cash-hungry biotech industry. End-of-January deadline is set to slide.
Revamp Of Small Business Funding Scheme Set For Yet Another Delay By Congress
SBIR update: House and Senate can't agree in time on bill prized by cash-hungry biotech industry. End-of-January deadline is set to slide.
House Passes SBIR Reauthorization, Loosens VC Restrictions
No single investor owns 50 percent or more of a firm and no single VC company controls a firm’s board, under House bill.